What is the price-to-earnings ratio of Inventiva?
The price-earnings ratio of Inventiva is currently -1.24.
Inventiva P/E 2024
Inventiva P/E
-1.24
Inventiva Dividend yield
Ticker
IVA.PA
ISIN
FR0013233012
WKN
A2DLV9
As of May 27, 2024, Inventiva's P/E ratio was -1.24, a -13.89% change from the -1.44 P/E ratio recorded in the previous year.
The Inventiva P/E history
Inventiva Aktienanalyse
What does Inventiva do?
Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Inventiva's P/E Ratio
The Price to Earnings (P/E) Ratio of Inventiva is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Inventiva's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Inventiva is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Inventiva’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Inventiva Stock
How has the price-earnings ratio of Inventiva changed compared to last year?
The price-to-earnings ratio of Inventiva has increased by -13.89% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Inventiva high compared to other companies?
Yes, the price-to-earnings ratio of Inventiva is high compared to other companies.
How does an increase in the price-earnings ratio of Inventiva affect the company?
An increase in the price-earnings ratio of Inventiva would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Inventiva affect the company?
A decrease in the price-earnings ratio of Inventiva would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Inventiva?
Some factors that influence the price-earnings ratio of Inventiva are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Inventiva pay?
Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.
What is the dividend yield of Inventiva?
The current dividend yield of Inventiva is .
When does Inventiva pay dividends?
Inventiva pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Inventiva?
Inventiva paid dividends every year for the past 0 years.
What is the dividend of Inventiva?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Inventiva located?
Inventiva is assigned to the 'Health' sector.
Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Inventiva from 5/27/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/27/2024.
When did Inventiva pay the last dividend?
The last dividend was paid out on 5/27/2024.
What was the dividend of Inventiva in the year 2023?
In the year 2023, Inventiva distributed 0 EUR as dividends.
In which currency does Inventiva pay out the dividend?
The dividends of Inventiva are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Inventiva
Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
